How is semaglutide administered?
Semaglutide for weight management and metabolic support is given as a subcutaneous injection — meaning the needle delivers the medication into the fatty tissue just beneath the skin, not into muscle. This is the same route used for insulin and many other biologics and peptides.
The once-weekly dosing schedule means there are 52 injection occasions per year. Over the course of a year or longer, injection site management becomes a meaningful part of the protocol rather than a minor detail. Done well, it is uneventful. Done poorly — same spot every week — it leads to tissue changes that alter how the drug behaves.
What are the three approved injection sites?
The manufacturer-approved and clinically recommended injection areas for subcutaneous semaglutide are:
- Abdomen— the preferred site for most patients. Use the area at least 2 inches (5 cm) away from the navel in any direction. Avoid the beltline and any scar tissue. The abdomen offers a generous surface area and is generally easy to access without assistance.
- Anterior or lateral thigh— the front or outer surface of the upper thigh. Accessible without assistance and suitable when abdominal sites need to rest. Avoid the inner thigh, where skin is thinner and more prone to bruising.
- Upper arm— the outer surface of the upper arm. This site typically requires assistance or a specific injection technique to reach reliably. It is included in prescribing guidance but is less commonly used as a primary site for self-injection.
All three areas contain subcutaneous adipose tissue in most patients. The goal is to deposit the medication in that fatty layer, not into muscle, which would change absorption kinetics.
How do you inject semaglutide step by step?
The following steps reflect general subcutaneous injection technique. Always follow your prescribing clinician’s specific instructions for your protocol.
- Choose an approved site— abdomen (2+ inches from navel), front or outer thigh, or outer upper arm, as directed by your clinician.
- Let the medication warm slightly— remove the vial from the refrigerator a few minutes before injection. Cold solution stings more on delivery.
- Clean and dry the site— wipe with an alcohol swab and allow to air dry fully before injecting.
- Inject subcutaneously as directed— insert the needle at the angle your clinician specifies (45–90 degrees depending on body composition). Inject slowly and hold briefly before withdrawing.
- Rotate to a new zone— move to an adjacent zone within the area at the next weekly injection. Use a systematic pattern (e.g., clockwise grid around the abdomen) so no zone is reused for several weeks.
- Dispose of the needle safely— place the used needle immediately in an approved sharps disposal container.
Once-weekly dosing means roughly 52 injections a year — enough that how you rotate sites, not just where you inject, shapes long-term absorption.
Why does injection site rotation matter?
Injecting into the same small area repeatedly causes a localized tissue reaction called lipohypertrophy — an accumulation of subcutaneous fat and fibrous connective tissue at the injection site. The tissue feels firm or rubbery compared to the surrounding area, and it often looks slightly raised or bumpy.
Lipohypertrophic tissue is not just a cosmetic issue. It absorbs injected medications more slowly and less predictably than healthy tissue. Research on insulin users — who have the most data on this topic — consistently shows that injecting into lipohypertrophic areas leads to more variable drug levels, which in that context means less predictable blood sugar control. The same principle applies to other subcutaneous medications including semaglutide.
Once lipohypertrophy develops, it typically resolves slowly over weeks to months if the affected area is rested. The standard guidance is to give identified lipohypertrophic zones at least 4–6 weeks of rest and to let a clinician evaluate whether the tissue has recovered before resuming use of that spot.
How do you rotate injection sites systematically?
The standard approach to rotation involves two levels: rotating between anatomical areas (abdomen, thigh, upper arm) and rotating within each area.
Within the abdomen, a practical system is to mentally divide the usable surface into a grid of thumbnail-sized zones. Move clockwise or in a consistent pattern through those zones each week, returning to the starting zone only after all others have been used — typically after several months. Some clinicians use clock positions (12 o’clock, 2 o’clock, 4 o’clock, etc. around the navel) as a reference.
The same grid approach applies to the thigh. Upper arm rotation is simpler because the usable surface area is smaller — divide it into a few zones and alternate.
Between-area rotation can be structured as a pattern: abdomen for several weeks, then thigh, then back to abdomen. Some patients prefer to stay within one area and rotate within it, moving to another area only if local tissue irritation develops. Clinicians typically have a preferred protocol based on patient anatomy and history.
What affects injection comfort and consistency?
Proper subcutaneous injection technique is straightforward once learned, but a few variables consistently affect both comfort and reliability of medication delivery:
- Needle angle and depth— subcutaneous injection uses a 45–90 degree needle angle depending on the amount of subcutaneous fat at the site and the needle length. Very lean individuals may need a more angled approach to avoid inadvertently reaching muscle. Clinicians provide individualized guidance here.
- Skin temperature— medication stored in the refrigerator should ideally be allowed to reach room temperature before injection. Cold solution stings more on delivery and may increase local tissue reaction at the injection site.
- Skin preparation— standard practice is to clean the site with an alcohol swab and allow it to dry fully before injecting. Wet skin from an alcohol swab can cause additional stinging.
- Injection speed— a slow, steady injection is generally more comfortable than a rapid push. After injecting, keep the needle in place for a few seconds before withdrawing to minimize leakback.
- Needle disposal— used needles should go in an approved sharps container, not household trash. This is a patient safety and community safety standard.
When should you contact your clinician about a local reaction?
Mild local reactions at the injection site are common, particularly in the first weeks of a new injection protocol. Transient redness, minor bruising, or slight itching at the injection site typically resolve within a day or two and are not cause for alarm.
Reasons to contact your clinician include: swelling, warmth, or firmness that persists beyond a few days (possible lipohypertrophy or local inflammation); signs of infection at the site (spreading redness, pus, fever); or significant pain that does not resolve quickly. Systemic allergic reactions — which are rare but possible with any injectable — require immediate medical attention.
In a clinician-supervised program, your prescribing provider is the right resource for injection technique questions specific to your anatomy and protocol. General guidance in this article does not substitute for that individualized instruction.